Compare Abeona Therapeutics Inc (ABEO) vs Prospect Capital Corporation (PSEC) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abeona Therapeutics Inc vs Prospect Capital Corporation — how do they compare? Abeona Therapeutics Inc trades at $6.73 (market cap $373.32M), while Prospect Capital Corporation trades at $2.21 (market cap $1.10B). The key difference: Prospect Capital Corporation is far larger — about 2.9× Abeona Therapeutics Inc's market cap, and Prospect Capital Corporation pays a 22.73% dividend while Abeona Therapeutics Inc pays none. Which is the better fit depends on your goals.
| ABEO | PSEC | |
|---|---|---|
Market Cap | $373.32M | $1.10B |
Sector | Health | Financials |
52-Week High | $7.23 | $3.47 |
52-Week Low | $4.17 | $2.15 |
Enterprise Value | $228.22M | — |
Dividend Yield | — | 22.73% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ABEO trades at $6.31, down 1.41% today, with a bullish technical outlook supported by moving averages. The company reported Q1 2026 results with revenue growth and beat EPS expectations, while maintaining strong profitability margins. Recent news highlights expansion of treatment centers and new cell therapy licensing.
Outlook remains positive with analyst consensus favoring Buy ratings (66.67%), though high RSI indicates potential near-term overbought conditions. Key risks include negative operating cash flow and reliance on new treatment adoption. Upside depends on continued commercial execution and pipeline advancements.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About Prospect Capital Corporation
Prospect Capital Corp is a closed-end investment company based in the United States. Its investment objective is to generate both current income and long-term capital appreciation through debt and equity investments. The company invests primarily in senior and subordinated debt and equity of private companies for acquisitions, divestitures, growth, development, recapitalizations, and other purposes. It makes investments, including lending in private equity, sponsored transactions, directly to companies, investments in structured credit, real estate, and syndicated debt.
Read more on PSEC →
